
08/22/2025
In 2025, artificial womb research continues with projects like the EXTrauterine Environment for Neonatal Development (EXTEND) system, aiming for human trials by the late 2020s to support premature infants by maintaining them in an amniotic-like fluid environment. While full-term ectogenesis is a distant concept, current systems are being refined in animal models to improve organ maturation and hemodynamic stability for mid-gestation fetuses, with the goal of reducing risks associated with early birth. Ethical discussions and the establishment of regulatory standards by bodies like the FDA are critical steps for the integration of these technologies into clinical practice.
https://medschool.duke.edu/blog/extending-hope-artificial-wombs-safer-neonatal-development
#
Dr. Zhang Qifeng, founder of Kaiwa Technology, has described the project as “mature” and commercially ready, with prototypes expected to sell for around US$14,000 in the coming year